Daiken Medical Co logo

7775 - Daiken Medical Co Share Price

¥558 0.0  0.0%

Last Trade - 28/09/20

Sector
Healthcare
Size
Small Cap
Market Cap £119.1m
Enterprise Value £124.2m
Revenue £61.3m
Position in Universe 2030th / 3864
Bullish
Bearish
Unlock 7775 Revenue
Momentum
Relative Strength (%)
1m -0.69%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -32.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
8,033 8,261 8,400 8,585 8,407 8,523 8,525 10,200 +1.2%
+25.3 +4.4 +9.2 -11.0 -16.0 -3.1 -3.77 +66.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 30 June 2020, Daiken Medical Co Ltd revenues decreased 13% to Y1.79B. Net income decreased 41% to Y136.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects SP L on retire. of fixed assets increase from Y0K to Y145K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from Y8.11 to Y4.75.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 7775
Graphical History

Revenue

7775 Revenue Unlock 7775 Revenue

Net Income

7775 Net Income Unlock 7775 Revenue

Normalised EPS

7775 Normalised EPS Unlock 7775 Revenue

PE Ratio Range

7775 PE Ratio Range Unlock 7775 Revenue

Dividend Yield Range

7775 Dividend Yield Range Unlock 7775 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
7775 EPS Forecasts Unlock 7775 Revenue
Profile Summary

DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Company’s products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.

Directors
Last Annual March 31st, 2020
Last Interim June 30th, 2020
Incorporated November 5, 1968
Public Since March 12, 2009
No. of Shareholders: 13,060
No. of Employees: 191
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Tokyo Stock Exchange
Shares in Issue 28,728,441
Free Float (0.0%)
Eligible for
ISAs
SIPPs
7775 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 7775
Upcoming Events for 7775
Tuesday 29th September, 2020
Dividend For 7775.T - 9.0000 JPY
Frequently Asked Questions for Daiken Medical Co
What is the Daiken Medical Co share price?

As of 28/09/20, shares in Daiken Medical Co are trading at ¥558, giving the company a market capitalisation of £119.1m. This share price information is delayed by 15 minutes.

How has the Daiken Medical Co share price performed this year?

Shares in Daiken Medical Co are currently trading at ¥558 and the price has moved by 7.1% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Daiken Medical Co price has moved by -0.9% over the past year.

What are the analyst and broker recommendations for Daiken Medical Co?

Of the analysts with advisory recommendations for Daiken Medical Co, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Daiken Medical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Daiken Medical Co next release its financial results?

Daiken Medical Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Daiken Medical Co dividend yield?

The Daiken Medical Co dividend yield is 3.58% based on the trailing twelve month period.

Does Daiken Medical Co pay a dividend?

Last year, Daiken Medical Co paid a total dividend of 20, and it currently has a trailing dividend yield of 3.58%. Looking ahead, shares in Daiken Medical Co are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01.

When does Daiken Medical Co next pay dividends?

Daiken Medical Co are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01. The historic dividend yield on Daiken Medical Co shares is currently 3.58%.

How do I buy Daiken Medical Co shares?

To buy shares in Daiken Medical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Daiken Medical Co?

Shares in Daiken Medical Co are currently trading at ¥558, giving the company a market capitalisation of £119.1m.

Where are Daiken Medical Co shares listed? Where are Daiken Medical Co shares listed?

Here are the trading details for Daiken Medical Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 7775
What kind of share is Daiken Medical Co?

Based on an overall assessment of its quality, value and momentum, Daiken Medical Co is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Daiken Medical Co share price forecast 2020?

Shares in Daiken Medical Co are currently priced at ¥558. At that level they are trading at 34.41% discount to the analyst consensus target price of 0.00.

Analysts covering Daiken Medical Co currently have a consensus Earnings Per Share (EPS) forecast of 29.25 for the next financial year.

How can I tell whether the Daiken Medical Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Daiken Medical Co. Over the past six months, the relative strength of its shares against the market has been -34.64%. At the current price of ¥558, shares in Daiken Medical Co are trading at -8.92% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Daiken Medical Co PE Ratio?

The Daiken Medical Co PE ratio based on its reported earnings over the past 12 months is 20.62. The shares are currently trading at ¥558.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Daiken Medical Co?

Daiken Medical Co's management team is headed by:

Mitsuru Yamada - PRE
Keiichi Yamada - EDR
Masayuki Yamada - EDR
Shinji Yanagihori - DSL
Yoshihisa Koga - IND
Takanori Mizuguchi - EXO
Who are the major shareholders of Daiken Medical Co?

Here are the top five shareholders of Daiken Medical Co based on the size of their shareholding:

Yamada (Keiichi) Individual Investor
Percentage owned: 17.67% (5.63m shares)
Yamada (Mitsuru) Individual Investor
Percentage owned: 12.56% (4.00m shares)
Yamada (Masayuki) Individual Investor
Percentage owned: 8.15% (2.60m shares)
Matthews International Capital Management, L.L.C. Investment Advisor
Percentage owned: 7.97% (2.54m shares)
Yamada (Yoneko) Individual Investor
Percentage owned: 3.35% (1.07m shares)
Similar to 7775
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.